Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR
Clinical trial NCT00854360 · COMPLETED
Trial details
- NCT number
- NCT00854360
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2009-05-01
- Enrollment
- 487
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.